Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150:e2022058859.

Article  PubMed  Google Scholar 

De Winter DP, Hulzebos C, Van ‘t Oever RM, De Haas M, Verweij EJ, Lopriore E. History and current standard of postnatal management in hemolytic disease of the fetus and newborn. Eur J Pediatr. 2022;182:489–500.

Article  PubMed  Google Scholar 

Du L, Ma X, Shen X, Bao Y, Chen L, Bhutani VK. Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production. Semin Perinatol. 2021;45:151351.

Article  PubMed  Google Scholar 

Tidmarsh GF, Wong RJ, Stevenson DK. End-tidal carbon monoxide and hemolysis. J Perinatol. 2014;34:577–81.

Article  CAS  PubMed  Google Scholar 

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.

Krog GR, Donneborg ML, Hansen BM, Lorenzen H, Clausen FB, Jensen KV, et al. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer. Pediatr Res. 2021;90:74–81.

Article  CAS  PubMed  Google Scholar 

Bakkeheim E, Bergerud U, Schmidt-Melbye AC, Akkök CA, Liestøl K, Fugelseth D, et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatr. 2009;98:1896–901.

Article  CAS  PubMed  Google Scholar 

Kardum D, Serdarušić I, Biljan B, Šantić K, Živković V, Kos M. Cord blood bilirubin and prediction of neonatal hyperbilirubinemia and perinatal infection in newborns at risk of hemolysis. Jornal de Pediatria. 2021;97:440–4.

Article  PubMed  Google Scholar 

Khairy MA, Abuelhamd WA, Elhawary IM, Mahmoud Nabayel AS. Early predictors of neonatal hyperbilirubinemia in full term newborn. Pediatr Neonatol. 2019;60:285–90.

Article  PubMed  Google Scholar 

Mehta R, Petrova A. Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility. Pediatr Neonatol. 2021;62:406–11.

Article  PubMed  Google Scholar 

Das S, Shastry S, Chakravarthy PK, Baliga PB. Clinical implication of immunohaematological tests in ABO haemolytic disease of newborn: Revisiting an old disease. Transfus Med. 2021;31:30–35.

Article  PubMed  Google Scholar 

Karabulut B, Arcagok BC. A neglected and promising predictor of severe hyperbilirubinemia due to Hemolysis: Carboxyhemoglobin. Fetal Pediatr Pathol. 2020;39:124–31.

Article  PubMed  Google Scholar 

Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics. 2002;109:e53.

Article  PubMed  Google Scholar 

Han S, Yu Z, Liu L, Wang J, Wei Q, Jiang C, et al. A model for predicting significant hyperbilirubinemia in neonates from China. Pediatrics. 2015;136:e896–905.

Article  PubMed  Google Scholar 

Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. J Perinatol. 2001;21:S63–72.

Article  PubMed  Google Scholar 

Bhutani VK, Srinivas S, Castillo Cuadrado ME, Aby JL, Wong RJ, Stevenson DK. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia. Acta Paediatr. 2016;105:e189–94.

Article  CAS  PubMed  Google Scholar 

Okuyama H, Yonetani M, Uetani Y, Nakamura H. End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia. Pediatr Int. 2001;43:329–33.

Article  CAS  PubMed  Google Scholar 

Bhatia A, Chua MC, Dela Puerta R, Rajadurai VS. Noninvasive detection of hemolysis with ETCOc measurement in neonates at risk for significant Hyperbilirubinemia. Neonatology. 2020;117:612–8.

Article  CAS  PubMed  Google Scholar 

Bao Y, Zhu J, Ma L, Zhang H, Sun L, Xu C, et al. An end-tidal carbon monoxide nomogram for term and late preterm Chinese newborns. J Pediatr. 2022;250:16–21.e3.

Article  PubMed  Google Scholar 

Bahr TM, Shakib JH, Stipelman CH, Kawamoto K, Lauer S, Christensen RD. Improvement initiative: end-tidal carbon monoxide measurement in newborns receiving phototherapy. J Pediatr. 2021;238:168–73.e2.

Article  CAS  PubMed  Google Scholar 

Zhan YL, Peng HB, Jin ZC, Su JF, Tan XY, Zhao L, et al. Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia. Front Pediatr. 2023;11:1154350.

Article  PubMed  PubMed Central  Google Scholar 

Javier MC, Krauss A, Nesin M. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs’ test-positive term neonates. Pediatrics. 2003;112:1333–37.

Article  PubMed  Google Scholar